Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Restricted and Repetitive Behaviors in Children With Autism
NCT05494398Phase 3Enrolling by invitation
- Sponsor
- Stanford University
- Start
- Mar 2024
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in Autism Spectrum Disorder (ASD), sponsored by Stanford University. Started Mar 2024; status: enrolling by invitation.
02
Drugs
acetylcysteine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05494398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494398.